Panagora Asset Management Inc Karuna Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$161.33 - $204.36 $242,801 - $307,561	1,505 Added 46.36%	4,751 $862,000
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $91,742 - $113,436	479 Added 17.31%	3,246 $637,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $342,526 - $767,621	2,767 New	2,767 $622,000
Q4 2020 Feb 10, 2021	SELL	$75.23 - $109.23 $17,528 - $25,450	-233 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$71.31 - $109.74 $16,615 - $25,569	233 New	233 $18,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.